Clinical Trial Update: Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating certolizumab pegol use in adults with rheumatoid arthritis assessing antibody response to influenza and pneumococcal vaccines; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Certolizumab pegol (certolizumab pegol)

Snippet

Sponsor: UCB Pharma | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2011-06-20